• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.系统蛋白质组分析鉴定转录因子 YY1 为 miR-34a 的直接靶标。
J Proteome Res. 2011 Feb 4;10(2):479-87. doi: 10.1021/pr1006697. Epub 2010 Dec 23.
2
Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis.通过联合脉冲 SILAC 和微阵列分析对 miR-34a 诱导的蛋白质和 mRNA 表达变化进行全基因组特征分析。
Mol Cell Proteomics. 2011 Aug;10(8):M111.010462. doi: 10.1074/mcp.M111.010462. Epub 2011 May 12.
3
miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation.微小RNA-34a-5p通过靶向转录因子YY1介导MYCT1上调来抑制肝癌的侵袭和转移。
Acta Histochem. 2020 Sep;122(6):151576. doi: 10.1016/j.acthis.2020.151576. Epub 2020 Jul 8.
4
Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma.全球基因组和蛋白质组分析确定与高危神经母细胞瘤相关的生物学途径。
J Proteome Res. 2010 Jan;9(1):373-82. doi: 10.1021/pr900701v.
5
microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.microRNA-7 是一种新型的 YY1 抑制剂,有助于结直肠肿瘤的发生。
Oncogene. 2013 Oct 17;32(42):5078-88. doi: 10.1038/onc.2012.526. Epub 2012 Dec 3.
6
Early targets of miR-34a in neuroblastoma.神经母细胞瘤中miR-34a的早期靶点。
Mol Cell Proteomics. 2014 Aug;13(8):2114-31. doi: 10.1074/mcp.M113.035808. Epub 2014 Jun 9.
7
Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis.阴阳1是微小RNA - 34家族的一个靶点,对胃癌发生有作用。
Oncotarget. 2014 Jul 15;5(13):5002-16. doi: 10.18632/oncotarget.2073.
8
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.miR-34a 是神经母细胞瘤体内有效的肿瘤抑制分子。
BMC Cancer. 2011 Jan 25;11:33. doi: 10.1186/1471-2407-11-33.
9
YY1-C/EBPα-miR34a regulatory circuitry is involved in renal cell carcinoma progression.YY1-C/EBPα-miR34a调控通路参与肾细胞癌进展。
Oncol Rep. 2014 Apr;31(4):1921-7. doi: 10.3892/or.2014.3005. Epub 2014 Jan 30.
10
YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis.YY1通过miR-9~RYBP轴调节黑色素瘤的肿瘤发生。
J Exp Clin Cancer Res. 2015 Jun 24;34(1):66. doi: 10.1186/s13046-015-0177-y.

引用本文的文献

1
Analysis of the p53/microRNA Network in Cancer.癌症中p53/微小RNA网络的分析
Adv Exp Med Biol. 2022;1385:187-228. doi: 10.1007/978-3-031-08356-3_7.
2
TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.TMEM97 通过 YY1 转录激活,并通过 GSK-3β/β-catenin 信号通路促进结直肠癌的进展。
Hum Cell. 2022 Sep;35(5):1535-1546. doi: 10.1007/s13577-022-00759-5. Epub 2022 Jul 30.
3
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers.微小RNA与JAK/STAT3信号传导:血液系统恶性肿瘤中一个新的有前景的治疗靶点
Genes Dis. 2021 Dec 3;9(4):849-867. doi: 10.1016/j.gendis.2021.10.009. eCollection 2022 Jul.
4
A Boolean Model of the Proliferative Role of the lncRNA XIST in Non-Small Cell Lung Cancer Cells.长链非编码RNA XIST在非小细胞肺癌细胞中增殖作用的布尔模型
Biology (Basel). 2022 Mar 22;11(4):480. doi: 10.3390/biology11040480.
5
MicroRNA-34a: the bad guy in age-related vascular diseases.miRNA-34a:与年龄相关的血管疾病中的“坏家伙”。
Cell Mol Life Sci. 2021 Dec;78(23):7355-7378. doi: 10.1007/s00018-021-03979-4. Epub 2021 Oct 26.
6
Detection of circRNA Biomarker for Acute Myocardial Infarction Based on System Biological Analysis of RNA Expression.基于RNA表达系统生物学分析的急性心肌梗死环状RNA生物标志物检测
Front Genet. 2021 Apr 30;12:686116. doi: 10.3389/fgene.2021.686116. eCollection 2021.
7
MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic.微小RNA-34a:强效肿瘤抑制因子、癌症干细胞抑制剂及潜在的抗癌治疗手段
Front Cell Dev Biol. 2021 Mar 8;9:640587. doi: 10.3389/fcell.2021.640587. eCollection 2021.
8
Recent trends in application of nanomaterials for the development of electrochemical microRNA biosensors.近年来纳米材料在电化学 miRNA 生物传感器发展中的应用趋势。
Mikrochim Acta. 2021 Mar 19;188(4):128. doi: 10.1007/s00604-021-04784-3.
9
The biological implications of Yin Yang 1 in the hallmarks of cancer.阴阳 1 在癌症标志中的生物学意义。
Theranostics. 2020 Mar 4;10(9):4183-4200. doi: 10.7150/thno.43481. eCollection 2020.
10
The role of noncoding RNAs in epithelial cancer.非编码RNA在上皮性癌中的作用。
Cell Death Discov. 2020 Mar 12;6:13. doi: 10.1038/s41420-020-0247-6. eCollection 2020.

本文引用的文献

1
Genome-wide analysis of YY2 versus YY1 target genes.全基因组分析 YY2 与 YY1 的靶基因。
Nucleic Acids Res. 2010 Jul;38(12):4011-26. doi: 10.1093/nar/gkq112. Epub 2010 Mar 9.
2
The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.miR-34a 对肝癌 HepG2 细胞蛋白质输出的影响。
Proteomics. 2010 Apr;10(8):1557-72. doi: 10.1002/pmic.200900646.
3
Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma.全球基因组和蛋白质组分析确定与高危神经母细胞瘤相关的生物学途径。
J Proteome Res. 2010 Jan;9(1):373-82. doi: 10.1021/pr900701v.
4
Causes and consequences of microRNA dysregulation in cancer.癌症中微小RNA失调的原因及后果。
Nat Rev Genet. 2009 Oct;10(10):704-14. doi: 10.1038/nrg2634.
5
MiR-34, SIRT1 and p53: the feedback loop.微小RNA-34、沉默调节蛋白1与p53:反馈回路
Cell Cycle. 2009 Mar 1;8(5):712-5. doi: 10.4161/cc.8.5.7753. Epub 2009 Mar 2.
6
miR-34a repression of SIRT1 regulates apoptosis.miR-34a对SIRT1的抑制作用调控细胞凋亡。
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13421-6. doi: 10.1073/pnas.0801613105. Epub 2008 Aug 28.
7
Proteomics joins the search for microRNA targets.蛋白质组学也加入了寻找微小RNA靶标的行列。
Cell. 2008 Aug 22;134(4):560-2. doi: 10.1016/j.cell.2008.08.008.
8
Widespread changes in protein synthesis induced by microRNAs.微小RNA诱导的蛋白质合成的广泛变化。
Nature. 2008 Sep 4;455(7209):58-63. doi: 10.1038/nature07228. Epub 2008 Jul 30.
9
The impact of microRNAs on protein output.微小RNA对蛋白质产出的影响。
Nature. 2008 Sep 4;455(7209):64-71. doi: 10.1038/nature07242. Epub 2008 Jul 30.
10
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.一项功能筛选将miR-34a鉴定为一种候选的神经母细胞瘤肿瘤抑制基因。
Mol Cancer Res. 2008 May;6(5):735-42. doi: 10.1158/1541-7786.MCR-07-2102.

系统蛋白质组分析鉴定转录因子 YY1 为 miR-34a 的直接靶标。

Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.

机构信息

Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Gaithersburg, Maryland 20877, USA.

出版信息

J Proteome Res. 2011 Feb 4;10(2):479-87. doi: 10.1021/pr1006697. Epub 2010 Dec 23.

DOI:10.1021/pr1006697
PMID:21182263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3679541/
Abstract

MicroRNA 34a (miR-34a) is a potential tumor suppressor gene and has been identified as a miRNA component of the p53 network. To better understand the biological pathways involved in miR-34a action, a parallel global protein and mRNA expression profiling on miR-34a treated neuroblastoma cells (IMR32) was performed using isotope-coded affinity tags (ICAT) and Affymetrix U133plus2 microarray, respectively. Global profiling showed that miR-34a causes much smaller mRNA expression changes compared to changes at the protein level. A total of 1495 proteins represented by two or more peptides were identified from the quantitative ICAT analysis, of which 143 and 192 proteins are significantly up- or down-regulated by miR-34a, respectively. Pathway analysis of these differentially expressed proteins showed the enrichment of apoptosis and cell death processes in up-regulated proteins but DNA replication and cell cycle processes in the down-regulated proteins. Ribosomal proteins are the most significant set down-regulated by miR-34a. Additionally, biological network analysis to identify direct interactions among the differentially expressed proteins demonstrated that the expression of the ubiquitous transcription factor YY1, as well as its downstream proteins, is significantly reduced by miR-34a. We further demonstrated that miR-34a directly targets YY1 through a miR-34a-binding site within the 3' UTR of YY1 using a luciferase reporter system. YY1 is a negative regulator of p53, and it plays an essential role in cancer biology. Therefore, YY1 is another important direct target of miR-34a which closely regulates TP53 activities.

摘要

微小 RNA34a(miR-34a)是一种潜在的肿瘤抑制基因,已被确定为 p53 网络中的 miRNA 成分。为了更好地了解 miR-34a 作用所涉及的生物学途径,我们分别使用同位素编码亲和标签(ICAT)和 Affymetrix U133plus2 微阵列对 miR-34a 处理的神经母细胞瘤细胞(IMR32)进行了平行的全局蛋白质和 mRNA 表达谱分析。全局分析表明,与蛋白质水平的变化相比,miR-34a 导致的 mRNA 表达变化要小得多。从定量 ICAT 分析中鉴定出了 1495 种由两个或更多肽代表的蛋白质,其中 143 和 192 种蛋白质分别被 miR-34a 显著上调或下调。对这些差异表达蛋白进行的途径分析表明,上调蛋白中富集了凋亡和细胞死亡过程,而下调蛋白中则富集了 DNA 复制和细胞周期过程。核糖体蛋白是受 miR-34a 下调最显著的一组蛋白。此外,识别差异表达蛋白之间直接相互作用的生物网络分析表明,普遍转录因子 YY1 的表达及其下游蛋白的表达,被 miR-34a 显著降低。我们进一步通过 YY1 3'UTR 中的 miR-34a 结合位点,利用荧光素酶报告系统证实 miR-34a 可直接靶向 YY1。YY1 是 p53 的负调节剂,在癌症生物学中起着重要作用。因此,YY1 是 miR-34a 的另一个重要直接靶点,它密切调节 TP53 活性。